Clinical Trial Update: Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of HRS-5965 in healthy subjects and individuals with renal impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis

Drugs mentioned

• HRS-5965

Snippet

Sponsor: Chengdu Suncadia Medicine Co., Ltd. | Conditions: Glomerulonephritis | Phase 1 | Status: COMPLETED